Approval · Notice of Compliance 11673 · 2010
RESTASIS: Notice of Compliance 11673
Issued August 19, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11673
- Date
- August 19, 2010
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anti-inflammatory / Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESTASIS | 02355655 | Marketed |
Medicinal ingredients
- CYCLOSPORINE 0.05 PER